What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest – Science
The post What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest appeared first on Links Medicus.
SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity – medRxiv Commentary: SARS-CoV-2 antibodies are detectable up to a year after infection, finds study – News Medical Commentary on Twitter Ahhh… A year has passed since people with Covid-19 were enrolled in a longitudinal study […]
The post [Preprint] SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity appeared first on Links Medicus.
Novel coronavirus really is seasonal, study suggests – LiveScience Original study: Climate and the spread of COVID-19 – Scientific Reports
The post Novel coronavirus really is seasonal, study suggests appeared first on Links Medicus.
Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose – Imperial College London Original study: Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose – Science Commentary on Twitter (thread – click for more) Just published @ScienceMagazine "After one dose, individuals with *prior infection* showed enhanced […]
The post Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose appeared first on Links Medicus.
Prone Positioning of Nonintubated Patients With Coronavirus Disease 2019—A Systematic Review and Meta-Analysis – Critical Care Medicine (link to abstract – $ for full-text)
The post M-A: Prone positioning of nonintubated patients with Covid-19 improve oxygenation variables without any reported serious adverse events – randomized trials with patient-relevant outcomes such as the need for intubation or mortality rates are required appeared first on Links Medicus.
Preventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – medRxiv
The post [Preprint] Preventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – “transferring patients proactively out of developing hotspots to less affected regions, well before high ICU workload situations emerge, will improve patient outcomes” appeared first on Links Medicus.
Incidence and Outcomes of Pneumonia in Patients With Heart Failure – Journal of the American College of Cardiology Commentaries: Pneumonia in HF Patients Is Common, Lethal, and Preventable – TCTMD AND Outcomes of Pneumonia in Patients With Heart Failure – American College of Cardiology
The post Study: Patients with heart failure have a much higher incidence of pneumonia than matched individuals in the population. The development of pneumonia in these patients is associated with a 3- to 4-fold higher risk of cardiovascular and all-cause death. appeared first on Links Medicus.
Shift work is associated with positive COVID-19 status in hospitalised patients – Thorax Commentary: Shift Work Linked to Increased Risk for COVID-19 Illness – HealthDay
The post Shift work is associated with positive COVID-19 status in hospitalized patients appeared first on Links Medicus.
Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis – Frontiers in Public Health
The post M-A: The viral shedding time (VST) determines disease transmission and the duration of infectiousness in SARS-CoV-2 infections – this study found that symptomatic infections, infected adults, persons with chronic diseases, and persons receiving corticosteroid treatment have longer VST appeared first on Links Medicus.
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 – JAMA Editorial: Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine – JAMA See also: Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021 – […]
The post Case series of 12 patients with cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination – all women younger than 60 years, with symptoms from 6 to 15 days after vaccination appeared first on Links Medicus.